Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators' survey
Although fever and hypothermia are common abnormal physical signs observed in patients admitted to intensive care units (ICU), little data exist on their optimal management. The objective of this study was to describe contemporary practices and determinants of management of temperature abnormalities...
Gespeichert in:
Veröffentlicht in: | Critical care (London, England) England), 2013-12, Vol.17 (6), p.R289-R289, Article R289 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | R289 |
---|---|
container_issue | 6 |
container_start_page | R289 |
container_title | Critical care (London, England) |
container_volume | 17 |
creator | Niven, Daniel J Laupland, Kevin B Tabah, Alexis Vesin, Aurélien Rello, Jordi Koulenti, Despoina Dimopoulos, George de Waele, Jan Timsit, Jean-Francois |
description | Although fever and hypothermia are common abnormal physical signs observed in patients admitted to intensive care units (ICU), little data exist on their optimal management. The objective of this study was to describe contemporary practices and determinants of management of temperature abnormalities among patients admitted to ICUs.
Site leaders of the multi-national EUROBACT study were surveyed regarding diagnosis and management of temperature abnormalities among patients admitted to their ICUs.
Of the 162 ICUs originally included in EUROBACT, responses were received from 139 (86%) centers in 23 countries in Europe (117), South America (8), Asia (5), North America (4), Australia (3) and Africa (2). A total of 117 (84%) respondents reported use of a specific temperature threshold in their ICU to define fever. A total of 14 different discrete levels were reported with a median of 38.2°C (inter-quartile range, IQR, 38.0°C to 38.5°C). The use of thermometers was protocolized in 91 (65%) ICUs and a wide range of methods were reportedly used, with axillary, tympanic and urinary bladder sites as the most common as primary modalities. Only 31 (22%) of respondents indicated that there was a formal written protocol for temperature control among febrile patients in their ICUs. In most or all cases practice was to control temperature, to use acetaminophen, and to perform a full septic workup in febrile patients and that this was usually directed by physician order. While reported practice was to treat nearly all patients with neurological impairment and most patients with acute coronary syndromes and infections, severe sepsis and septic shock, this was not the case for most patients with liver failure and fever.
A wide range of definitions and management practices were reported regarding temperature abnormalities in the critically ill. Documenting temperature abnormality management practices, including variability in clinical care, is important to inform planning of future studies designed to optimize infection and temperature management strategies in the critically ill. |
doi_str_mv | 10.1186/cc13153 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4057370</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A534778164</galeid><sourcerecordid>A534778164</sourcerecordid><originalsourceid>FETCH-LOGICAL-c502t-3400085f868eadef5da9253b9a7022e28462e9556cdad82cdbf65b1dad52bdca3</originalsourceid><addsrcrecordid>eNptkd9rFDEQxxdRbK3ifyABH-rL1vzYZLM-COdZtVAoSA98kTCbnV0ju8k12T24_96UO4sFycNkZj7zZYZvUbxm9IIxrd5bywST4klxyiqlSkWbH0_zX6iq1FLIk-JFSr8pZbVW4nlxwivBFavkafHzs4PBh-QSAd-RCTwMOKGfSejJjNMWI8xLRAKtD3GC0c174jy5Wm_SBwLkcvP95tNqfZtrO0yzG2AOMZ2TtMQd7l8Wz3oYE746xrNi8-Xydv2tvL75erVeXZdWUj6XoqKUatlrpRE67GUHDZeibaCmnCPXleLYSKlsB53mtmt7JVuWE8nbzoI4Kz4edLdLO2Fn8_4RRrONboK4NwGcedzx7pcZws5UVNaiplng3VEghrslH2ImlyyOI3gMSzJMykZxoTTP6NsDOsCIxvk-ZEV7j5uVFFVda6aqTF38h8qvw8nZ4LF3uf5o4PwwYGNIKWL_sD2j5t5jc_Q4k2_-PfaB-2uq-AOtd6Fs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1559623682</pqid></control><display><type>article</type><title>Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators' survey</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>SpringerLink Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Springer Nature OA Free Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Niven, Daniel J ; Laupland, Kevin B ; Tabah, Alexis ; Vesin, Aurélien ; Rello, Jordi ; Koulenti, Despoina ; Dimopoulos, George ; de Waele, Jan ; Timsit, Jean-Francois</creator><creatorcontrib>Niven, Daniel J ; Laupland, Kevin B ; Tabah, Alexis ; Vesin, Aurélien ; Rello, Jordi ; Koulenti, Despoina ; Dimopoulos, George ; de Waele, Jan ; Timsit, Jean-Francois ; EUROBACT Investigators ; the EUROBACT Investigators</creatorcontrib><description>Although fever and hypothermia are common abnormal physical signs observed in patients admitted to intensive care units (ICU), little data exist on their optimal management. The objective of this study was to describe contemporary practices and determinants of management of temperature abnormalities among patients admitted to ICUs.
Site leaders of the multi-national EUROBACT study were surveyed regarding diagnosis and management of temperature abnormalities among patients admitted to their ICUs.
Of the 162 ICUs originally included in EUROBACT, responses were received from 139 (86%) centers in 23 countries in Europe (117), South America (8), Asia (5), North America (4), Australia (3) and Africa (2). A total of 117 (84%) respondents reported use of a specific temperature threshold in their ICU to define fever. A total of 14 different discrete levels were reported with a median of 38.2°C (inter-quartile range, IQR, 38.0°C to 38.5°C). The use of thermometers was protocolized in 91 (65%) ICUs and a wide range of methods were reportedly used, with axillary, tympanic and urinary bladder sites as the most common as primary modalities. Only 31 (22%) of respondents indicated that there was a formal written protocol for temperature control among febrile patients in their ICUs. In most or all cases practice was to control temperature, to use acetaminophen, and to perform a full septic workup in febrile patients and that this was usually directed by physician order. While reported practice was to treat nearly all patients with neurological impairment and most patients with acute coronary syndromes and infections, severe sepsis and septic shock, this was not the case for most patients with liver failure and fever.
A wide range of definitions and management practices were reported regarding temperature abnormalities in the critically ill. Documenting temperature abnormality management practices, including variability in clinical care, is important to inform planning of future studies designed to optimize infection and temperature management strategies in the critically ill.</description><identifier>ISSN: 1364-8535</identifier><identifier>EISSN: 1466-609X</identifier><identifier>EISSN: 1364-8535</identifier><identifier>DOI: 10.1186/cc13153</identifier><identifier>PMID: 24326145</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Acetaminophen - therapeutic use ; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Antipyretics - therapeutic use ; Bacteremia - diagnosis ; Cardiac patients ; Care and treatment ; Clinical Protocols ; Coronary heart disease ; Diagnosis ; Fever - diagnosis ; Fever - etiology ; Fever - therapy ; Health aspects ; Humans ; Hypothermia ; Hypothermia - diagnosis ; Hypothermia - etiology ; Hypothermia - therapy ; Hypothermia, Induced ; Intensive Care Units ; Medical research ; Medicine, Experimental ; Risk factors ; Strategic planning (Business) ; Thermometers</subject><ispartof>Critical care (London, England), 2013-12, Vol.17 (6), p.R289-R289, Article R289</ispartof><rights>COPYRIGHT 2013 BioMed Central Ltd.</rights><rights>Copyright © 2013 Niven et al., licensee BioMed Central Ltd. 2013 Niven et al., licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c502t-3400085f868eadef5da9253b9a7022e28462e9556cdad82cdbf65b1dad52bdca3</citedby><cites>FETCH-LOGICAL-c502t-3400085f868eadef5da9253b9a7022e28462e9556cdad82cdbf65b1dad52bdca3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057370/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057370/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,861,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24326145$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Niven, Daniel J</creatorcontrib><creatorcontrib>Laupland, Kevin B</creatorcontrib><creatorcontrib>Tabah, Alexis</creatorcontrib><creatorcontrib>Vesin, Aurélien</creatorcontrib><creatorcontrib>Rello, Jordi</creatorcontrib><creatorcontrib>Koulenti, Despoina</creatorcontrib><creatorcontrib>Dimopoulos, George</creatorcontrib><creatorcontrib>de Waele, Jan</creatorcontrib><creatorcontrib>Timsit, Jean-Francois</creatorcontrib><creatorcontrib>EUROBACT Investigators</creatorcontrib><creatorcontrib>the EUROBACT Investigators</creatorcontrib><title>Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators' survey</title><title>Critical care (London, England)</title><addtitle>Crit Care</addtitle><description>Although fever and hypothermia are common abnormal physical signs observed in patients admitted to intensive care units (ICU), little data exist on their optimal management. The objective of this study was to describe contemporary practices and determinants of management of temperature abnormalities among patients admitted to ICUs.
Site leaders of the multi-national EUROBACT study were surveyed regarding diagnosis and management of temperature abnormalities among patients admitted to their ICUs.
Of the 162 ICUs originally included in EUROBACT, responses were received from 139 (86%) centers in 23 countries in Europe (117), South America (8), Asia (5), North America (4), Australia (3) and Africa (2). A total of 117 (84%) respondents reported use of a specific temperature threshold in their ICU to define fever. A total of 14 different discrete levels were reported with a median of 38.2°C (inter-quartile range, IQR, 38.0°C to 38.5°C). The use of thermometers was protocolized in 91 (65%) ICUs and a wide range of methods were reportedly used, with axillary, tympanic and urinary bladder sites as the most common as primary modalities. Only 31 (22%) of respondents indicated that there was a formal written protocol for temperature control among febrile patients in their ICUs. In most or all cases practice was to control temperature, to use acetaminophen, and to perform a full septic workup in febrile patients and that this was usually directed by physician order. While reported practice was to treat nearly all patients with neurological impairment and most patients with acute coronary syndromes and infections, severe sepsis and septic shock, this was not the case for most patients with liver failure and fever.
A wide range of definitions and management practices were reported regarding temperature abnormalities in the critically ill. Documenting temperature abnormality management practices, including variability in clinical care, is important to inform planning of future studies designed to optimize infection and temperature management strategies in the critically ill.</description><subject>Acetaminophen - therapeutic use</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>Antipyretics - therapeutic use</subject><subject>Bacteremia - diagnosis</subject><subject>Cardiac patients</subject><subject>Care and treatment</subject><subject>Clinical Protocols</subject><subject>Coronary heart disease</subject><subject>Diagnosis</subject><subject>Fever - diagnosis</subject><subject>Fever - etiology</subject><subject>Fever - therapy</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Hypothermia</subject><subject>Hypothermia - diagnosis</subject><subject>Hypothermia - etiology</subject><subject>Hypothermia - therapy</subject><subject>Hypothermia, Induced</subject><subject>Intensive Care Units</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Risk factors</subject><subject>Strategic planning (Business)</subject><subject>Thermometers</subject><issn>1364-8535</issn><issn>1466-609X</issn><issn>1364-8535</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkd9rFDEQxxdRbK3ifyABH-rL1vzYZLM-COdZtVAoSA98kTCbnV0ju8k12T24_96UO4sFycNkZj7zZYZvUbxm9IIxrd5bywST4klxyiqlSkWbH0_zX6iq1FLIk-JFSr8pZbVW4nlxwivBFavkafHzs4PBh-QSAd-RCTwMOKGfSejJjNMWI8xLRAKtD3GC0c174jy5Wm_SBwLkcvP95tNqfZtrO0yzG2AOMZ2TtMQd7l8Wz3oYE746xrNi8-Xydv2tvL75erVeXZdWUj6XoqKUatlrpRE67GUHDZeibaCmnCPXleLYSKlsB53mtmt7JVuWE8nbzoI4Kz4edLdLO2Fn8_4RRrONboK4NwGcedzx7pcZws5UVNaiplng3VEghrslH2ImlyyOI3gMSzJMykZxoTTP6NsDOsCIxvk-ZEV7j5uVFFVda6aqTF38h8qvw8nZ4LF3uf5o4PwwYGNIKWL_sD2j5t5jc_Q4k2_-PfaB-2uq-AOtd6Fs</recordid><startdate>20131210</startdate><enddate>20131210</enddate><creator>Niven, Daniel J</creator><creator>Laupland, Kevin B</creator><creator>Tabah, Alexis</creator><creator>Vesin, Aurélien</creator><creator>Rello, Jordi</creator><creator>Koulenti, Despoina</creator><creator>Dimopoulos, George</creator><creator>de Waele, Jan</creator><creator>Timsit, Jean-Francois</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20131210</creationdate><title>Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators' survey</title><author>Niven, Daniel J ; Laupland, Kevin B ; Tabah, Alexis ; Vesin, Aurélien ; Rello, Jordi ; Koulenti, Despoina ; Dimopoulos, George ; de Waele, Jan ; Timsit, Jean-Francois</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c502t-3400085f868eadef5da9253b9a7022e28462e9556cdad82cdbf65b1dad52bdca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Acetaminophen - therapeutic use</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>Antipyretics - therapeutic use</topic><topic>Bacteremia - diagnosis</topic><topic>Cardiac patients</topic><topic>Care and treatment</topic><topic>Clinical Protocols</topic><topic>Coronary heart disease</topic><topic>Diagnosis</topic><topic>Fever - diagnosis</topic><topic>Fever - etiology</topic><topic>Fever - therapy</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Hypothermia</topic><topic>Hypothermia - diagnosis</topic><topic>Hypothermia - etiology</topic><topic>Hypothermia - therapy</topic><topic>Hypothermia, Induced</topic><topic>Intensive Care Units</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Risk factors</topic><topic>Strategic planning (Business)</topic><topic>Thermometers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Niven, Daniel J</creatorcontrib><creatorcontrib>Laupland, Kevin B</creatorcontrib><creatorcontrib>Tabah, Alexis</creatorcontrib><creatorcontrib>Vesin, Aurélien</creatorcontrib><creatorcontrib>Rello, Jordi</creatorcontrib><creatorcontrib>Koulenti, Despoina</creatorcontrib><creatorcontrib>Dimopoulos, George</creatorcontrib><creatorcontrib>de Waele, Jan</creatorcontrib><creatorcontrib>Timsit, Jean-Francois</creatorcontrib><creatorcontrib>EUROBACT Investigators</creatorcontrib><creatorcontrib>the EUROBACT Investigators</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Critical care (London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Niven, Daniel J</au><au>Laupland, Kevin B</au><au>Tabah, Alexis</au><au>Vesin, Aurélien</au><au>Rello, Jordi</au><au>Koulenti, Despoina</au><au>Dimopoulos, George</au><au>de Waele, Jan</au><au>Timsit, Jean-Francois</au><aucorp>EUROBACT Investigators</aucorp><aucorp>the EUROBACT Investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators' survey</atitle><jtitle>Critical care (London, England)</jtitle><addtitle>Crit Care</addtitle><date>2013-12-10</date><risdate>2013</risdate><volume>17</volume><issue>6</issue><spage>R289</spage><epage>R289</epage><pages>R289-R289</pages><artnum>R289</artnum><issn>1364-8535</issn><eissn>1466-609X</eissn><eissn>1364-8535</eissn><abstract>Although fever and hypothermia are common abnormal physical signs observed in patients admitted to intensive care units (ICU), little data exist on their optimal management. The objective of this study was to describe contemporary practices and determinants of management of temperature abnormalities among patients admitted to ICUs.
Site leaders of the multi-national EUROBACT study were surveyed regarding diagnosis and management of temperature abnormalities among patients admitted to their ICUs.
Of the 162 ICUs originally included in EUROBACT, responses were received from 139 (86%) centers in 23 countries in Europe (117), South America (8), Asia (5), North America (4), Australia (3) and Africa (2). A total of 117 (84%) respondents reported use of a specific temperature threshold in their ICU to define fever. A total of 14 different discrete levels were reported with a median of 38.2°C (inter-quartile range, IQR, 38.0°C to 38.5°C). The use of thermometers was protocolized in 91 (65%) ICUs and a wide range of methods were reportedly used, with axillary, tympanic and urinary bladder sites as the most common as primary modalities. Only 31 (22%) of respondents indicated that there was a formal written protocol for temperature control among febrile patients in their ICUs. In most or all cases practice was to control temperature, to use acetaminophen, and to perform a full septic workup in febrile patients and that this was usually directed by physician order. While reported practice was to treat nearly all patients with neurological impairment and most patients with acute coronary syndromes and infections, severe sepsis and septic shock, this was not the case for most patients with liver failure and fever.
A wide range of definitions and management practices were reported regarding temperature abnormalities in the critically ill. Documenting temperature abnormality management practices, including variability in clinical care, is important to inform planning of future studies designed to optimize infection and temperature management strategies in the critically ill.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>24326145</pmid><doi>10.1186/cc13153</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1364-8535 |
ispartof | Critical care (London, England), 2013-12, Vol.17 (6), p.R289-R289, Article R289 |
issn | 1364-8535 1466-609X 1364-8535 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4057370 |
source | MEDLINE; DOAJ Directory of Open Access Journals; SpringerLink Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Springer Nature OA Free Journals; PubMed Central; Alma/SFX Local Collection |
subjects | Acetaminophen - therapeutic use Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Antipyretics - therapeutic use Bacteremia - diagnosis Cardiac patients Care and treatment Clinical Protocols Coronary heart disease Diagnosis Fever - diagnosis Fever - etiology Fever - therapy Health aspects Humans Hypothermia Hypothermia - diagnosis Hypothermia - etiology Hypothermia - therapy Hypothermia, Induced Intensive Care Units Medical research Medicine, Experimental Risk factors Strategic planning (Business) Thermometers |
title | Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators' survey |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T05%3A59%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnosis%20and%20management%20of%20temperature%20abnormality%20in%20ICUs:%20a%20EUROBACT%20investigators'%20survey&rft.jtitle=Critical%20care%20(London,%20England)&rft.au=Niven,%20Daniel%20J&rft.aucorp=EUROBACT%20Investigators&rft.date=2013-12-10&rft.volume=17&rft.issue=6&rft.spage=R289&rft.epage=R289&rft.pages=R289-R289&rft.artnum=R289&rft.issn=1364-8535&rft.eissn=1466-609X&rft_id=info:doi/10.1186/cc13153&rft_dat=%3Cgale_pubme%3EA534778164%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1559623682&rft_id=info:pmid/24326145&rft_galeid=A534778164&rfr_iscdi=true |